Four identified genetic defects cause impaired thiamine transport and metabolism [7,8]; specifically, the outcomes of SLC19A2 dysfunction due to genetic mutation may include megaloblastic anemia (TRMA), sensory-neural hearing loss (sensorineural deafness), hyperglycemia, and diabetes mellitus [16]. Here, SLC19A2 is linked to thiamine-responsive megaloblastic anemia syndrome.